HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Shalmali Pal


Should maintenance therapy serve as the standard of care in metastatic non-small-cell lung cancer?

December 06, 2010

Patients with incurable NSCLC are less likely to progress to second-linetherapy with the right maintenance regimen. But maintenance therapyalso means committing patients to continuous treatment without anybreaks or chances to recover from adverse events.

Industry update: New treatments prove mettle in relapsed and refractory patients

December 05, 2010

CAL-101 and GA101 demonstrate active results in indolent B-cell non-Hodgkin’s lymphoma and chronic lymphocytic leukemia while a secondary analysis of a pralatrexate (Folotyn) trial shows a benefit for peripheral T-cell lymphoma patients who fail second-line therapy.